Navigation Links
Cancer Research Institute Announces June Cancer Immunotherapy Awareness Month; 1-800-FLOWERS.COM® and The Fund for Park Avenue to Support and Promote Awareness
Date:5/8/2013

New York, NY (PRWEB) May 08, 2013

The Cancer Research Institute (CRI) declares June “Cancer Immunotherapy Awareness Month” to increase awareness of cancer immunotherapy, a new class of cancer treatment that mobilizes the immune system to fight the disease and represents the most immediate hope for curing patients with any type of cancer.

Many members of the public are not aware of cancer immunotherapy’s ability to treat cancer and its potential to offer safer and more effective treatment options for all cancer patients. Cancer Immunotherapy Awareness Month will raise awareness of this sea change in cancer treatment, and enlist public support in helping to accelerate development of immunotherapies for patients with all types of cancer.

“For 60 years, CRI has remained steadfast in its dedication to realizing immunotherapy’s potential to treat and cure cancer,” said Jill O’Donnell-Tormey, Ph.D., chief executive officer and director of scientific affairs at the Cancer Research Institute. “Because of this work, today safe and powerful new immune-based treatment options are finally available, and we are dedicated to increasing awareness and support to bring them to more patients sooner.”

During the month of June, the Cancer Research Institute will host a series of free-to-the-public webinars each week in June (schedule below). The webinars will feature scientific experts who will share the latest news in cancer immunotherapy, including breakthrough new treatment strategies as well as challenges the field still faces in its attempts to optimize immune-based cancer therapies. Audience participants will be able to submit questions for the experts in a moderated Q&A session following the presentation.

On June 7, and every first Friday in June thereafter, CRI will promote “Wear White for a Cure Day” – white signifying immunotherapy’s power to treat all cancers. On this day, individuals including employees at companies are encouraged to wear white in support of efforts to speed cancer immunotherapy development. Participants can register for the event through the CRI website or via Facebook. Donors and fundraisers for the event will receive a wristband and T shirt featuring CRI’s “I’Mmunotherapy and I’m curing cancer” slogan.

Throughout the month of June, 1-800-FLOWERS.COM®, an official sponsor of CRI’s Cancer Immunotherapy Awareness Month, will feature a special collection of white-themed flowers and gifts on its e-commerce sites, with 10 percent of the net proceeds from the sale of the items within the “Fight with White” collection to be donated to the Cancer Research Institute.

This summer, white flowers—Baby Dragon Wing begonias, specifically—will carpet the malls along Park Avenue from 54th to 86th Streets on Manhattan’s Upper East Side. According to Barbara McLaughlin, president of The Fund for Park Avenue, the not-for-profit organization that oversees the annual mall plantings, “the Fund is pleased that this year’s white begonias can play a role in CRI’s inaugural Cancer Immunotherapy Awareness Month.” The Park Avenue begonias are grown from seed each year by Van de Wetering Greenhouses in Jamesport, Long Island. A planting ceremony will be held on June 4th.

White also stands for new hope and new beginnings, O’Donnell-Tormey says. “Immune cells are also called white blood cells, and the scientists working to develop these revolutionary new treatments wear white lab coats, so white is a perfect color for cancer immunotherapy awareness.”

In preparation for Cancer Immunotherapy Awareness Month, the Cancer Research Institute has recently relaunched its website (http://www.cancerresearch.org) to provide more information to patients interested in learning more about cancer immunotherapy. In addition to pages describing how immunotherapy is impacting many different types of cancer, the CRI site also now features a cancer immunotherapy clinical trial finder, a valuable service that connects cancer patients to cutting-edge clinical studies of promising new immune-based cancer treatments.

“Our work at CRI is focused not only on fostering new discoveries by supporting laboratory research, but also on accelerating and optimizing development of immunotherapies for cancer,” said O’Donnell-Tormey. “One way we are helping the field move forward faster is to encourage more patients to consider enrolling in a cancer immunotherapy clinical trial by using our free trial finder service.”

To register for the webinars and for the June 7 “Wear White for a Cure Day” event, visit http://www.cancerresearch.org/fightwithwhite.

Webinar Schedule – All dates 2pm ET:
June 4: Kunle Odunsi, MD, PhD, Roswell Park Cancer Institute, Buffalo, NY
June 10: Carl June, MD, University of Pennsylvania School of Medicine, Philadelphia, PA
June 18: Jedd Wolchok, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY
June 25: Philip Greenberg, MD, Fred Hutchinson Cancer Research Center, Seattle, WA

Video: NASDAQ Opening Bell Ceremony featuring 1-800-FLOWERS.COM® and Cancer Research Institute’s Cancer Immunotherapy Awareness Month, May 7, 2013
http://mktvideo.nasdaq.com/MarketSiteOpenCloseVideos/201305/mo_050713.wmv

Read the full story at http://www.prweb.com/releases/2013/5/prweb10710960.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Colleen’s Dream Foundation Makes Its First Ovarian Cancer Research Grant to John Hopkins University to Celebrate World Ovarian Cancer Day
2. Cancer biorepository speeds clinical trials, drug development, Moffitt analysis shows
3. Amplification of a Stat5 gene produces excess oncogenic protein that drives prostate cancer spread
4. Prostate Cancer May Be Deadlier for the Uninsured
5. Duke researchers describe how breast cancer cells acquire drug resistance
6. Cholesterol Drugs Might Boost Kidney Cancer Survival
7. Initiation of breast cancer treatment varies by race; patient-doctor communication is key
8. Sleep Woes Tied to Prostate Cancer Risk in Study
9. Study Shows Dual Targeting of HER2 and HR-positive Metastatic Breast Cancer Improves Survival Rates
10. New class of drug targets skin cancer
11. Drake University’s Phi Gamma Delta (FIJI) “Kicking Cancer with NFL Kicker Billy Cundiff” Exceeds Fundraising Expectations Raising Over $8,000 for Colleen’s Dream Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology: